JP2012512858A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012512858A5 JP2012512858A5 JP2011541582A JP2011541582A JP2012512858A5 JP 2012512858 A5 JP2012512858 A5 JP 2012512858A5 JP 2011541582 A JP2011541582 A JP 2011541582A JP 2011541582 A JP2011541582 A JP 2011541582A JP 2012512858 A5 JP2012512858 A5 JP 2012512858A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- poly
- molecule
- glycan
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000004676 glycans Chemical group 0.000 claims 40
- -1 poly (alkylene glycol Chemical compound 0.000 claims 38
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 33
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 33
- 229910052739 hydrogen Inorganic materials 0.000 claims 32
- 239000001257 hydrogen Substances 0.000 claims 32
- 229910052760 oxygen Inorganic materials 0.000 claims 26
- 150000002431 hydrogen Chemical group 0.000 claims 22
- 229910052717 sulfur Inorganic materials 0.000 claims 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims 19
- 229920001184 polypeptide Polymers 0.000 claims 18
- 102000004196 processed proteins & peptides Human genes 0.000 claims 18
- 238000000034 method Methods 0.000 claims 12
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 8
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 8
- 239000003153 chemical reaction reagent Substances 0.000 claims 7
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 4
- 238000006243 chemical reaction Methods 0.000 claims 4
- 125000006575 electron-withdrawing group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 4
- 102000014914 Carrier Proteins Human genes 0.000 claims 3
- 108010078791 Carrier Proteins Proteins 0.000 claims 3
- 229920001282 polysaccharide Polymers 0.000 claims 3
- 239000005017 polysaccharide Substances 0.000 claims 3
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 2
- 108010060123 Conjugate Vaccines Proteins 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 229940031670 conjugate vaccine Drugs 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 claims 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 239000012948 isocyanate Substances 0.000 claims 2
- 150000002513 isocyanates Chemical class 0.000 claims 2
- HHACNQLZWJFHIC-UHFFFAOYSA-N isocyano cyanate Chemical compound [C-]#[N+]OC#N HHACNQLZWJFHIC-UHFFFAOYSA-N 0.000 claims 2
- FGANIOIYLZMNBP-UHFFFAOYSA-N isothiocyanatosulfanylimino(sulfanylidene)methane Chemical compound S=C=NSN=C=S FGANIOIYLZMNBP-UHFFFAOYSA-N 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- LHKVDVFVJMYULK-UHFFFAOYSA-N nitrosylazide Chemical compound [N-]=[N+]=NN=O LHKVDVFVJMYULK-UHFFFAOYSA-N 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 2
- 150000003457 sulfones Chemical class 0.000 claims 2
- 125000003831 tetrazolyl group Chemical group 0.000 claims 2
- 125000005031 thiocyano group Chemical group S(C#N)* 0.000 claims 2
- JSPLKZUTYZBBKA-UHFFFAOYSA-N trioxidane Chemical compound OOO JSPLKZUTYZBBKA-UHFFFAOYSA-N 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- XJLITJHUQRBWPN-UHFFFAOYSA-N 2-acetamidoacetic acid;4-[2-(4-carbamimidoylphenyl)iminohydrazinyl]benzenecarboximidamide Chemical group CC(=O)NCC(O)=O.C1=CC(C(=N)N)=CC=C1NN=NC1=CC=C(C(N)=N)C=C1 XJLITJHUQRBWPN-UHFFFAOYSA-N 0.000 claims 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims 1
- 102000019034 Chemokines Human genes 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 claims 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000003951 Erythropoietin Human genes 0.000 claims 1
- 108090000394 Erythropoietin Proteins 0.000 claims 1
- 108010051696 Growth Hormone Proteins 0.000 claims 1
- 102000018997 Growth Hormone Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- 102000015696 Interleukins Human genes 0.000 claims 1
- 108010063738 Interleukins Proteins 0.000 claims 1
- 102000001938 Plasminogen Activators Human genes 0.000 claims 1
- 108010001014 Plasminogen Activators Proteins 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 230000000890 antigenic effect Effects 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 1
- 239000003114 blood coagulation factor Substances 0.000 claims 1
- 229940019700 blood coagulation factors Drugs 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 229940105423 erythropoietin Drugs 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 230000001279 glycosylating effect Effects 0.000 claims 1
- 239000000122 growth hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 230000000877 morphologic effect Effects 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
- 229940127126 plasminogen activator Drugs 0.000 claims 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 230000001850 reproductive effect Effects 0.000 claims 1
- 238000002741 site-directed mutagenesis Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13901408P | 2008-12-19 | 2008-12-19 | |
| GB0823309.0 | 2008-12-19 | ||
| GBGB0823309.0A GB0823309D0 (en) | 2008-12-19 | 2008-12-19 | Functionalising reagents and their uses |
| US61/139,014 | 2008-12-19 | ||
| PCT/GB2009/002924 WO2010070300A2 (en) | 2008-12-19 | 2009-12-21 | Functionalising reagents and their uses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015137984A Division JP6240122B2 (ja) | 2008-12-19 | 2015-07-09 | 官能基化試薬およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012512858A JP2012512858A (ja) | 2012-06-07 |
| JP2012512858A5 true JP2012512858A5 (enExample) | 2013-02-07 |
| JP5877712B2 JP5877712B2 (ja) | 2016-03-08 |
Family
ID=40343997
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011541582A Active JP5877712B2 (ja) | 2008-12-19 | 2009-12-21 | 官能基化試薬およびその使用 |
| JP2015137984A Active JP6240122B2 (ja) | 2008-12-19 | 2015-07-09 | 官能基化試薬およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015137984A Active JP6240122B2 (ja) | 2008-12-19 | 2015-07-09 | 官能基化試薬およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8785595B2 (enExample) |
| EP (2) | EP2373675B1 (enExample) |
| JP (2) | JP5877712B2 (enExample) |
| CN (2) | CN104558098B (enExample) |
| ES (2) | ES2556328T3 (enExample) |
| GB (1) | GB0823309D0 (enExample) |
| PL (2) | PL2373675T3 (enExample) |
| WO (1) | WO2010070300A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0823309D0 (en) | 2008-12-19 | 2009-01-28 | Univ Bath | Functionalising reagents and their uses |
| GB201007356D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIIa |
| AU2012294448A1 (en) | 2011-08-08 | 2014-03-06 | Boyce Thompson Institute For Plant Research | Small molecule compounds for the control of nematodes |
| MX2014001503A (es) | 2011-08-08 | 2015-01-14 | California Inst Of Techn | Compuestos de moleculas pequeñas que controlan los nematodos patogenos de plantas e insectos. |
| EP2907823A1 (en) * | 2014-02-14 | 2015-08-19 | Gene Signal International SA | Polypeptide fragments of 168A-T2 and compositions comprising them for use in treating cancer |
| GB201419108D0 (en) * | 2014-10-27 | 2014-12-10 | Glythera Ltd | Materials and methods relating to linkers for use in antibody drug conjugates |
| EP3503904A4 (en) | 2016-08-25 | 2020-03-25 | California Institute of Technology | ASCAROSIDE TREATMENT OF EOSINOPHILIC OESOPHAGITIS |
| EP3829647A1 (en) | 2018-07-31 | 2021-06-09 | Astrazeneca AB | Linkers and conjugates |
| US12473323B2 (en) | 2019-05-17 | 2025-11-18 | California Institute Of Technology | Ascaroside derivatives and methods of use |
| CN115998707A (zh) * | 2021-10-21 | 2023-04-25 | 福州大学 | 一种聚二硫多肽纳米粒及其制备方法和多肽药物口服制剂 |
| CN115181091A (zh) * | 2022-06-21 | 2022-10-14 | 江苏联环药业股份有限公司 | 一种贝他斯汀的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| CA1236454A (en) * | 1984-06-27 | 1988-05-10 | John J. Tsai | Monomeric cationic glycoside derivatives |
| US4719272A (en) * | 1984-06-27 | 1988-01-12 | National Starch And Chemical Corporation | Monomeric cationic glycoside derivatives |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5079361A (en) * | 1987-01-15 | 1992-01-07 | Celltech Limited | Thiol-reactive cross-linking reagents |
| DE3942355A1 (de) * | 1989-12-21 | 1991-06-27 | Boehringer Mannheim Gmbh | N- und o-substituierte aminophenolderivate, zwischenprodukte zu deren herstellung, deren verwendung als hydrolasesubstrate, ein entsprechendes bestimmungsverfahren und hierfuer geeignetes diagnostisches mittel |
| EP0575545B1 (en) | 1991-03-15 | 2003-05-21 | Amgen Inc. | Pegylation of polypeptides |
| DK0672142T3 (da) | 1992-12-04 | 2001-06-18 | Medical Res Council | Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse |
| US5446090A (en) * | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US6309646B1 (en) * | 1996-05-09 | 2001-10-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates |
| US6602498B2 (en) * | 2000-02-22 | 2003-08-05 | Shearwater Corporation | N-maleimidyl polymer derivatives |
| WO2003025133A2 (en) | 2001-09-14 | 2003-03-27 | Mimeon, Inc. | Methods of making glycolmolecules with enhanced activities and uses thereof |
| US20040214228A9 (en) | 2001-09-14 | 2004-10-28 | Ganesh Venkataraman | Methods of evaluating glycomolecules for enhanced activities |
| CN1630530A (zh) | 2002-01-18 | 2005-06-22 | 比奥根艾迪克Ma公司 | 聚亚烷基聚合物及其用途 |
| NZ538624A (en) * | 2002-09-09 | 2007-01-26 | Nektar Therapeutics Al Corp | Water-soluble polymer alkanals |
| JP2004262781A (ja) * | 2003-02-28 | 2004-09-24 | Noguchi Inst | 蛍光糖鎖プローブ |
| US20050074895A1 (en) | 2003-09-05 | 2005-04-07 | Bio-Rad Laboratories, Inc. | Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins |
| CN101223137A (zh) * | 2005-07-11 | 2008-07-16 | 默克公司 | 制备氢化异二氢吲哚速激肽受体拮抗剂的方法 |
| GB0823309D0 (en) | 2008-12-19 | 2009-01-28 | Univ Bath | Functionalising reagents and their uses |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
-
2008
- 2008-12-19 GB GBGB0823309.0A patent/GB0823309D0/en not_active Ceased
-
2009
- 2009-12-21 ES ES09795797.1T patent/ES2556328T3/es active Active
- 2009-12-21 ES ES15151649.9T patent/ES2674099T3/es active Active
- 2009-12-21 JP JP2011541582A patent/JP5877712B2/ja active Active
- 2009-12-21 CN CN201410643896.5A patent/CN104558098B/zh active Active
- 2009-12-21 EP EP09795797.1A patent/EP2373675B1/en active Active
- 2009-12-21 US US13/140,690 patent/US8785595B2/en active Active
- 2009-12-21 PL PL09795797T patent/PL2373675T3/pl unknown
- 2009-12-21 EP EP15151649.9A patent/EP2886132B1/en active Active
- 2009-12-21 WO PCT/GB2009/002924 patent/WO2010070300A2/en not_active Ceased
- 2009-12-21 CN CN200980154905.1A patent/CN102317305B/zh active Active
- 2009-12-21 PL PL15151649T patent/PL2886132T3/pl unknown
-
2014
- 2014-06-26 US US14/315,784 patent/US9212148B2/en active Active
-
2015
- 2015-07-09 JP JP2015137984A patent/JP6240122B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012512858A5 (enExample) | ||
| JP6971927B2 (ja) | リスペリドンハプテンへの抗体及びその使用 | |
| Egami et al. | Trifluoromethylation reactions for the synthesis of β-trifluoromethylamines. | |
| CN102317305B (zh) | 硫醇基官能化试剂及其用途 | |
| CN111902429A (zh) | 多聚体双环肽配体 | |
| AU2019200005A1 (en) | Multi-specific molecules | |
| RU2008135433A (ru) | Гибриды рекомбинантных антител-белков стресса | |
| JP2005506277A5 (enExample) | ||
| DE502005010449D1 (de) | Erfindung betreffend glp-1 und exendin | |
| US20210122785A1 (en) | Peptide ligands for binding to il-17 | |
| JP2006517939A5 (enExample) | ||
| CN103476798A (zh) | 在粘合物质和可铁宁的粘合体上结合有抗-可铁宁抗体的复合体及其用途 | |
| CN107174838B (zh) | 一种含锆金属有机骨架材料修饰的开管毛细管柱及其应用 | |
| RU2017103462A (ru) | Материалы и способы, связанные с линкерами для применения в конъюгатах лекарственного средства и белка | |
| CN109661407A (zh) | 融合蛋白构建体 | |
| Asano et al. | Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc | |
| RU2012142654A (ru) | Производные комплекса металл-сален и способ их получения | |
| CN103601662B (zh) | 一种褪黑素半抗原、褪黑素完全抗原及其制备方法和应用 | |
| CN116891454B (zh) | 小分子抑制剂及制备方法与其在制备抗癌药物中的应用 | |
| CN100340543C (zh) | 氰戊菊酯半抗原化合物、合成方法及其用途 | |
| JP2008531475A (ja) | アミノチオール含有分子をビヒクルと複合化する方法 | |
| FJ et al. | Pneumonia from Nocardia nova in lung cancer | |
| Picha et al. | Engineering peptide therapeutics using MIMETIBODY™ technology | |
| WO2025248090A1 (en) | Novel brd4 binders | |
| JP6038774B2 (ja) | タンパク性物質結合性低分子化合物 |